##  [Novartis achieves Tier 1 in the 2026 CCLA Corporate Mental Health Benchmark](/stories/novartis-achieves-tier-1-2026-ccla-corporate-mental-health-benchmark "Novartis achieves Tier 1 in the 2026 CCLA Corporate Mental Health Benchmark") 

 #  Novartis achieves Tier 1 in the 2026 CCLA Corporate Mental Health Benchmark 

Novartis has reached the highest performance tier in the CCLA Corporate Mental Health Benchmark, recognizing a comprehensive approach to workplace mental health, wellbeing and employee support.



 

 Oct 08, 2026 

Novartis has achieved Tier 1 status in the [2026 CCLA Corporate Mental Health Benchmark](https://www.ccla.co.uk/mental-health), an independent assessment that evaluates how large companies support workplace mental health, employee wellbeing, psychological safety and access to care through leadership, culture, governance and employee experience. Tier 1 is the highest level of recognition awarded by CCLA and reflects a comprehensive and strategic approach to supporting employees across leadership, culture, policies and access to resources.

At Novartis, supporting mental health and wellbeing is fundamental to creating an environment where people can thrive, grow and contribute at their best. As an innovative medicines company, we know that breakthrough innovation depends on the creativity, curiosity and resilience of our people. That is why we continue to invest in workplace mental health, employee wellbeing and psychological safety across our organization.

### How Novartis supports workplace mental health and wellbeing

Mental health and wellbeing are embedded into Novartis’ culture, leadership expectations and ways of working. Our approach focuses on reducing mental health risks, promoting awareness and capability, and supporting employees with access to care.

In 2026, Novartis launched CareConnect, a global Employee Care Program that provides all employees worldwide with access to confidential mental health, wellbeing and caregiving support. The program extends support beyond employees to eligible family members and aims to provide earlier, more personalized access to care.

Novartis also invests in manager training, employee learning programs and global awareness initiatives designed to build capability and reduce stigma around mental health. In 2026, more than 2,000 managers participated in Leading with Care, a dedicated mental health training program, while employees completed learning focused on mental health awareness, preventative support and how to access available resources.

 ![Rob Kowalski - Chief People & Organization Officer](/sites/novartis_com/files/styles/crop_freeform/public/2026-06/rob-kowalski-bio-370.jpg?itok=AfqsCtc9 "Rob Kowalski - Chief People & Organization Officer")

 



  
*"Creating an environment where people can thrive is fundamental to our culture and our ability to deliver on our purpose. This recognition reflects the commitment of leaders, employees and partners across Novartis to foster a workplace where mental health is prioritized, conversations are encouraged and personalized support is accessible to everyone who needs it. We are proud of the progress we have made over the past several years and remain committed to continuously raising the bar in how we support the mental health and wellbeing of our people."*

**Rob Kowalski,** Chief People & Organization Officer at Novartis.







### Continuing the journey

While this recognition is an important milestone, our focus remains on continuous improvement. As we continue to evolve how we work, we remain committed to a workplace culture grounded in performance and care, one that enables our people to achieve more together and create lasting impact for patients and society.



 



###  Learn more about how Novartis cares for the mental health and wellbeing of its people. 



 [Click here](/about/inclusion/caring-mental-health-and-wellbeing-our-people "Click here")